CK1-IN-1 |
| Katalog-Nr.GC34536 |
CK1-IN-1 ist ein Inhibitor der Caseinkinase 1 (CK1), der aus dem Patent WO2015119579A1, Verbindung 1c, extrahiert wurde und einen IC50-Wert von 15 nM, 16 nM, 73 nM fÜr CK1δ bzw. CK1ε, p38σ MAPK hat.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1784751-20-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CK1-IN-1 is a casein kinase 1 (CK1) inhibitor extracted from patent WO2015119579A1, compound 1c, has IC50s of 15 nM, 16 nM, 73 nM for CK1δ, and CK1ε, p38σ MAPK, respectively[1]. CKIδ|15 nM (IC50)|CK1?|16 nM (IC50)
[1]. Filip LACO,et al. 2,4,5-tri-substituted azole-based casein kinase 1 inhibitors as inducers for cardiomyogenesis. WO2015119579A1.
Average Rating: 5 (Based on Reviews and 4 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *